Alexion Pharmaceuticals - Virtual Exhibit Hall - Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2023 | Mayo Clinic School of Continuous Professional Development

Alexion Pharmaceuticals - Exhibitor
Company Website Contact Information: Marlin Jones marlin.jones@alexion.com 480-842-1477	Virtual Exhibit Hall Home Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. Additional Materials: HUS Resource Guide (Transplant) HUS Diagnostic Pathway Brochure

Alexion Pharmaceuticals - Exhibitor

Contact Information:

Marlin Jones
marlin.jones@alexion.com
480-842-1477

Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for nearly 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Additional Materials:

HUS Resource Guide (Transplant)
HUS Diagnostic Pathway Brochure

Mayo Clinic School of Continuous Professional Development

You are here

Alexion Pharmaceuticals - Virtual Exhibit Hall - Mayo Clinic Nephrology, Hypertension and Kidney Transplantation Update for the Clinician 2023